Partners sells majority stake in PCI Pharma to Kohlberg & Co; Blackstone snaps up Takeda’s Japanese consumer health unit; Branford strikes first Fund 2 investment

Takeda Pharmaceutical is divesting its Japanese consumer healthcare business to Blackstone Group and Branford Castle Partners buys Fibrix Filtration.